Developer docs
API playgroundTry for free, no card

Search company profiles

DSM

Full company profile

uuid0006po3

Namestring
DSM
Legal namestring
DSM-Firmenich AG
Websiteurl
dsm.com
Company typeenum
Public
Founded yearint
1902
Descriptiontext

DSM, now operating as DSM-Firmenich AG following its May 2024 merger with Swiss fragrance and ingredients company Firmenich, is a global science-based company that develops and supplies ingredients and solutions across nutrition, health, and beauty. Headquartered in Heerlen (Netherlands) with a Swiss-incorporated parent (DSM-Firmenich AG), the company serves large B2B customers in food and beverage manufacturing, dietary supplements, animal feed and aquaculture, and personal care/cosmetics, and operates a publicly listed equity on Euronext Amsterdam (otcqx:RDSMY) with a 10,000+ employee base.

Core offerings include vitamins, minerals, enzymes, flavors, colors, bioactive compounds, algae oils, glycan-based eubiotics (acquired via Midori USA in 2021), precision-fermented animal-free dairy proteins (commercialized via the Vivici joint venture with Fonterra), plant-based protein ingredients (Vestkorn Milling, 2021), digital precision farming tools (Prodap, 2022), and exclusive US sunscreen active bemotrizinol marketed as Parsol Shield following FDA approval. The technology stack combines proprietary platforms — Midori's glycan identification, Vivici's microbial precision fermentation, and aquaculture-specific feed enzymes — with global manufacturing and regulatory capabilities.

The business model is B2B ingredient supply via direct enterprise sales to major CPG, food, animal nutrition, and personal care manufacturers, supplemented by specialty ingredient licensing (vitamins, enzymes, flavors, UV filters) and recurring long-term supply agreements. Revenue is supported by an investment-grade balance sheet (Moody's A3, S&P A-), an €8 billion Debt Issuance Program, and an €1.8 billion revolving credit facility concluded in 2024, which together fund ongoing R&D and acquisitions in growth adjacencies such as alternative proteins and sustainability-oriented feed solutions.

Short descriptiontext

DSM-Firmenich is a global science-based company supplying vitamins, enzymes, bioactives, precision-fermented and plant-based proteins, glycan eubiotics, and UV filters to B2B customers in food, nutrition, animal feed, and personal care.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHeerlen, Netherlands
HQ citystring
Heerlen
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
nutritional ingredients, animal nutrition solutions, personal care ingredients, plant-based proteins, precision fermentation
Industry5 codes
1Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes)
CodeCRADAOAMPrimaryYes
2Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
CodeCRADAOAJPrimaryNo
3Manufacturing, Private Label & Co-Manufacturing for Animal Diets
CodeHLAMAHAOPrimaryNo
4Plant-Based Prepared Meals & Convenience Foods Manufacturing
CodeAFAKAGALPrimaryNo
5Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B)
CodeAFAHAJAIPrimaryNo
NAICS code2 codes
  • Food Manufacturing311
  • Dairy Product Manufacturing3115
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Specialty Ingredients
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Ingredients and solutions B2B sales
TypeSubscription Recurring
Description

DSM generates primary revenue through selling ingredients, solutions, and formulated products to food, beverage, supplement, animal feed, personal care, and cosmetics manufacturers. Revenue is generated through long-term supply agreements and formula-based contracts with major CPG companies.

market.us
2Specialty ingredients licensing
TypeLicensing Royalties
Description

DSM licenses proprietary ingredients and technologies including vitamins, enzymes, flavors, colors, and bioactive compounds to manufacturers across nutrition and personal care industries.

marketreportanalytics.com
3UV filter ingredients (Parsol Shield)
TypeOne Time License
Description

Exclusive supply of bemotrizinol (BEMT) under the Parsol Shield brand for sunscreen formulations following FDA approval, representing a new revenue stream from the US market.

reason.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Parsol Shield
Description

Sunscreen ingredient brand under which DSM offers bemotrizinol (BEMT) following FDA approval

reason.com
+1 more record
Core offering1 text field

DSM-Firmenich manufactures and supplies science-based specialty ingredients — vitamins, minerals, enzymes, flavors, colors, bioactive compounds, UV filters, plant-based proteins, and glycan-based eubiotics — to food, beverage, dietary supplement, animal feed, aquaculture, and personal care manufacturers. The company also delivers precision farming digital tools, feed additives, and fermentation-derived dairy proteins through partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • DSM's goal to reduce livestock emissions by 2030 supported by precision farming and eubiotics solutions
+1 more record
Product and service8 records
1Vitamins, minerals and enzymes
CategoryNutritional ingredients
Description

Vitamin, mineral, and enzyme ingredients supplied to food, beverage, dietary supplement, and nutraceutical manufacturers for product formulation and fortification.

2Flavors, colors and bioactive compounds
3Parsol Shield (bemotrizinol / BEMT UV filter)
4Vestkorn pea- and bean-derived ingredients
CategoryPlant-based proteins
Description

Pea- and bean-derived protein ingredients supplied to plant-based food, pet food, and animal feed manufacturers.

5Prodap precision farming solutions
CategoryAnimal nutrition and precision farming
Description

Animal nutrition and technology solutions, including feed additives and digital tools, supplied to livestock and aquaculture operators to improve farm efficiency and sustainability.

6Midori glycan-based eubiotics
CategoryAnimal nutrition eubiotics
Description

Glycan-based eubiotic ingredients sourced from natural food sugars that modulate the gut microbiome in animals, supporting antibiotic replacement and sustainability in farming.

7Vivitein BLG (precision fermentation dairy protein)
CategoryPrecision fermentation ingredients
Description

Animal-free beta-lactoglobulin dairy protein ingredient produced via precision fermentation through the Vivici joint venture, intended for food applications.

8Aquaculture nutrition solutions
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-01
Description

Brazilian animal nutrition and technology company acquired by Royal DSM on September 1, 2022. Acquisition enhances DSM's digital solutions, promotes more efficient farming, and supports sustainability commitments through precision farming technologies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-11-29
Description

Norwegian company acquired by Royal DSM for €65 million in November 2021. Supplies pea- and bean-derived ingredients for plant-based foods, pet food, and animal feed. Deal closed in Q4 2021, expanding DSM's presence in the plant-based protein market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-07-27
Description

Biotech start-up acquired by Royal DSM for US$63 million to bolster portfolio of targeted eubiotics. Midori's platform identifies glycans from natural food sugars that modulate the gut microbiome in animals, supporting sustainability and antibiotic replacement in farming practices.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Precision fermentation company backed by DSM and Fonterra, founded 2.5 years ago. Vivici has launched its first commercial ingredient (Vivitein BLG) and uses milestone-driven fundraising approach. Company is financing transition from pilot-scale to industrial-scale dairy protein production using precision fermentation technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

IFF is a direct peer following its combination with DuPont Nutrition & Biosciences, offering overlapping ingredients portfolios across food, beverage, health, and personal care — closely mirroring the combined DSM-Firmenich scope.

TypeDirect peer
Description

Givaudan is a direct peer as a global leader in fragrances, flavors, and taste & wellbeing ingredients, directly comparable to Firmenich's legacy business and now part of the combined DSM-Firmenich platform.

TypeDirect peer
Description

Symrise is a direct peer operating across taste, nutrition, health, and scent, serving similar food, beverage, pet food, and personal care customers with a comparable B2B ingredients model.

TypeDirect peer
Description

Novonesis is a direct peer in enzymes, cultures, and fermentation-based ingredients — overlapping with DSM's enzyme, gut health, and precision fermentation portfolios in food and animal nutrition.

TypeDirect peer
Description

Kerry Group is a direct peer in taste and nutrition solutions, serving global food and beverage manufacturers with functional ingredients and flavor systems comparable to DSM's food and beverage business.

TypeBroad incumbent
Description

ADM is a broad incumbent in agricultural processing and human/animal nutrition ingredients, competing with DSM across nutrition solutions while operating a much wider commodity origination footprint.

TypeBroad incumbent
Description

Cargill is a broad incumbent in food ingredients and animal nutrition, having previously sold its cultures and enzymes business to DSM and now competing across the broader ingredients and feed value chain.

TypeDirect peer
Description

Corbion is a direct peer in food ingredients and biochemicals with overlapping capabilities in lactic acid, preservation, and alternative proteins (including precision fermentation), making it highly comparable to DSM's ingredient portfolio.

TypeDirect peer
Description

Tate & Lyle is a direct peer as a B2B food and beverage ingredients supplier focused on texturants, sweeteners, and fortification, serving many of the same global CPG customers as DSM.

TypeBroad incumbent
Description

BASF is a broad incumbent operating a Nutrition & Health division that competes with DSM in vitamins, carotenoids, and feed enzymes as part of a much larger chemical conglomerate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A37 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DSM

Specialty Ingredientsdsm.com

DSM-Firmenich is a global science-based company supplying vitamins, enzymes, bioactives, precision-fermented and plant-based proteins, glycan eubiotics, and UV filters to B2B customers in food, nutrition, animal feed, and personal care.

What DSM does

DSM, now operating as DSM-Firmenich AG following its May 2024 merger with Swiss fragrance and ingredients company Firmenich, is a global science-based company that develops and supplies ingredients and solutions across nutrition, health, and beauty. Headquartered in Heerlen (Netherlands) with a Swiss-incorporated parent (DSM-Firmenich AG), the company serves large B2B customers in food and beverage manufacturing, dietary supplements, animal feed and aquaculture, and personal care/cosmetics, and operates a publicly listed equity on Euronext Amsterdam (otcqx:RDSMY) with a 10,000+ employee base.

Core offerings include vitamins, minerals, enzymes, flavors, colors, bioactive compounds, algae oils, glycan-based eubiotics (acquired via Midori USA in 2021), precision-fermented animal-free dairy proteins (commercialized via the Vivici joint venture with Fonterra), plant-based protein ingredients (Vestkorn Milling, 2021), digital precision farming tools (Prodap, 2022), and exclusive US sunscreen active bemotrizinol marketed as Parsol Shield following FDA approval. The technology stack combines proprietary platforms — Midori's glycan identification, Vivici's microbial precision fermentation, and aquaculture-specific feed enzymes — with global manufacturing and regulatory capabilities.

The business model is B2B ingredient supply via direct enterprise sales to major CPG, food, animal nutrition, and personal care manufacturers, supplemented by specialty ingredient licensing (vitamins, enzymes, flavors, UV filters) and recurring long-term supply agreements. Revenue is supported by an investment-grade balance sheet (Moody's A3, S&P A-), an €8 billion Debt Issuance Program, and an €1.8 billion revolving credit facility concluded in 2024, which together fund ongoing R&D and acquisitions in growth adjacencies such as alternative proteins and sustainability-oriented feed solutions.

DSM firmographics

Firmographics
Name
DSM
Legal name
DSM-Firmenich AG
Website
https://dsm.com
Company type
Public
Founded year
1902
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
DSM-Firmenich is a global science-based company supplying vitamins, enzymes, bioactives, precision-fermented and plant-based proteins, glycan eubiotics, and UV filters to B2B customers in food, nutrition, animal feed, and personal care.
Ownership category
akta.pro rank

DSM industry classification

Industry
Product category
Specialty Ingredients
NAICS
Food Manufacturing (311), Dairy Product Manufacturing (3115)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro primary industry
Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)
akta.pro secondary industries
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ), Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO), Plant-Based Prepared Meals & Convenience Foods Manufacturing (AFAKAGAL), Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B) (AFAHAJAI)

Keywords

  • Nutritional ingredients
  • Animal nutrition solutions
  • Personal care ingredients
  • Plant-based proteins
  • Precision fermentation

Where DSM is headquartered

Location

Headquarters

HQ city
Heerlen
HQ country
Netherlands
HQ region
Europe

Markets served

DSM business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Ingredients and solutions B2B sales: DSM generates primary revenue through selling ingredients, solutions, and formulated products to food, beverage, supplement, animal feed, personal care, and cosmetics manufacturers. Revenue is generated through long-term supply agreements and formula-based contracts with major CPG companies.
  2. Specialty ingredients licensing: DSM licenses proprietary ingredients and technologies including vitamins, enzymes, flavors, colors, and bioactive compounds to manufacturers across nutrition and personal care industries.
  3. UV filter ingredients (Parsol Shield): Exclusive supply of bemotrizinol (BEMT) under the Parsol Shield brand for sunscreen formulations following FDA approval, representing a new revenue stream from the US market.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

DSM product offering

Product offering

Core offering

DSM-Firmenich manufactures and supplies science-based specialty ingredients — vitamins, minerals, enzymes, flavors, colors, bioactive compounds, UV filters, plant-based proteins, and glycan-based eubiotics — to food, beverage, dietary supplement, animal feed, aquaculture, and personal care manufacturers. The company also delivers precision farming digital tools, feed additives, and fermentation-derived dairy proteins through partnerships.

Differentiator

Problem solved

Functional benefit

Brands

  • Parsol Shield: Sunscreen ingredient brand under which DSM offers bemotrizinol (BEMT) following FDA approval
  • Vivitein BLG

Products and services

  • Vitamins, minerals and enzymes Vitamin, mineral, and enzyme ingredients supplied to food, beverage, dietary supplement, and nutraceutical manufacturers for product formulation and fortification.
  • Flavors, colors and bioactive compounds
  • Parsol Shield (bemotrizinol / BEMT UV filter)
  • Vestkorn pea- and bean-derived ingredients Pea- and bean-derived protein ingredients supplied to plant-based food, pet food, and animal feed manufacturers.
  • Prodap precision farming solutions Animal nutrition and technology solutions, including feed additives and digital tools, supplied to livestock and aquaculture operators to improve farm efficiency and sustainability.
  • Midori glycan-based eubiotics Glycan-based eubiotic ingredients sourced from natural food sugars that modulate the gut microbiome in animals, supporting antibiotic replacement and sustainability in farming.
  • Vivitein BLG (precision fermentation dairy protein) Animal-free beta-lactoglobulin dairy protein ingredient produced via precision fermentation through the Vivici joint venture, intended for food applications.
  • Aquaculture nutrition solutions

Quantifiable outcome

  • DSM's goal to reduce livestock emissions by 2030 supported by precision farming and eubiotics solutions
  • +1 more outcomes

Companies that use DSM

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

DSM technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

DSM partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • ProdapcoreStrategic or Co-development Partner · 1 September 2022Brazilian animal nutrition and technology company acquired by Royal DSM on September 1, 2022. Acquisition enhances DSM's digital solutions, promotes more efficient farming, and supports sustainability commitments through precision farming technologies.
  • Vestkorn MillingcoreStrategic or Co-development Partner · 29 November 2021Norwegian company acquired by Royal DSM for €65 million in November 2021. Supplies pea- and bean-derived ingredients for plant-based foods, pet food, and animal feed. Deal closed in Q4 2021, expanding DSM's presence in the plant-based protein market.
  • Midori USAcoreStrategic or Co-development Partner · 27 July 2021Biotech start-up acquired by Royal DSM for US$63 million to bolster portfolio of targeted eubiotics. Midori's platform identifies glycans from natural food sugars that modulate the gut microbiome in animals, supporting sustainability and antibiotic replacement in farming practices.
  • VivicicoreStrategic or Co-development PartnerPrecision fermentation company backed by DSM and Fonterra, founded 2.5 years ago. Vivici has launched its first commercial ingredient (Vivitein BLG) and uses milestone-driven fundraising approach. Company is financing transition from pilot-scale to industrial-scale dairy protein production using precision fermentation technology.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

DSM competitors and assessment

Company assessment

Direct peers

  • International Flavors & Fragrances (IFF): IFF is a direct peer following its combination with DuPont Nutrition & Biosciences, offering overlapping ingredients portfolios across food, beverage, health, and personal care — closely mirroring the combined DSM-Firmenich scope.
  • Givaudan: Givaudan is a direct peer as a global leader in fragrances, flavors, and taste & wellbeing ingredients, directly comparable to Firmenich's legacy business and now part of the combined DSM-Firmenich platform.
  • Symrise: Symrise is a direct peer operating across taste, nutrition, health, and scent, serving similar food, beverage, pet food, and personal care customers with a comparable B2B ingredients model.
  • Novonesis (Novozymes + Chr. Hansen): Novonesis is a direct peer in enzymes, cultures, and fermentation-based ingredients — overlapping with DSM's enzyme, gut health, and precision fermentation portfolios in food and animal nutrition.
  • Kerry Group: Kerry Group is a direct peer in taste and nutrition solutions, serving global food and beverage manufacturers with functional ingredients and flavor systems comparable to DSM's food and beverage business.
  • Corbion: Corbion is a direct peer in food ingredients and biochemicals with overlapping capabilities in lactic acid, preservation, and alternative proteins (including precision fermentation), making it highly comparable to DSM's ingredient portfolio.
  • Tate & Lyle: Tate & Lyle is a direct peer as a B2B food and beverage ingredients supplier focused on texturants, sweeteners, and fortification, serving many of the same global CPG customers as DSM.

Broad incumbents

  • ADM (Archer Daniels Midland): ADM is a broad incumbent in agricultural processing and human/animal nutrition ingredients, competing with DSM across nutrition solutions while operating a much wider commodity origination footprint.
  • Cargill: Cargill is a broad incumbent in food ingredients and animal nutrition, having previously sold its cultures and enzymes business to DSM and now competing across the broader ingredients and feed value chain.
  • BASF (Nutrition & Health division): BASF is a broad incumbent operating a Nutrition & Health division that competes with DSM in vitamins, carotenoids, and feed enzymes as part of a much larger chemical conglomerate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

DSM social profiles

Digital presence

DSM financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DSM leadership team

Management profile

Number of profiles

Profiles7 records

DSM subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

DSM funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DSM M&A and investment

M&A and investment

M&A37 records

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DSM

What does DSM do?

DSM-Firmenich manufactures and supplies science-based specialty ingredients — vitamins, minerals, enzymes, flavors, colors, bioactive compounds, UV filters, plant-based proteins, and glycan-based eubiotics — to food, beverage, dietary supplement, animal feed, aquaculture, and personal care manufacturers. The company also delivers precision farming digital tools, feed additives, and fermentation-derived dairy proteins through partnerships.

Is DSM a public or private company?

DSM is a public company. It is classified as public and is currently operating.

When was DSM founded?

DSM was founded in 1902. It employs 5,001 to 10,000 people.

Where is DSM based?

DSM is headquartered in Heerlen, Netherlands, in the Europe region.

How does DSM make money?

Three revenue lines are on record. Ingredients and solutions B2B sales are the primary driver. The others are specialty ingredients licensing and UV filter ingredients (Parsol Shield).

Who are DSM's main competitors?

Direct peers on record are International Flavors & Fragrances (IFF), Givaudan, Symrise, Novonesis (Novozymes + Chr. Hansen), Kerry Group, Corbion and Tate & Lyle. Broad incumbents are ADM (Archer Daniels Midland), Cargill and BASF (Nutrition & Health division).

Does DSM have an API?

No public API is recorded for DSM.

What industry is DSM in?

DSM's product category is Specialty Ingredients. Its primary akta.pro industry code is CRADAOAM, Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes), with a secondary code of CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesInfants Aqueous Vitamin D Oral Drop Market Research: Trends and Forecast 2035 – PR TimesA market research report on infants' aqueous vitamin D oral drops outlines drivers such as rising awareness of infant nutrition, concern over vitamin D deficiency, and preference for convenient liquid formulations. It segments the market by type, application, product characteristics and distribution channel, and identifies North America, Europe and Asia-Pacific as key regions. Named participants include Koninklijke DSM, Zhejiang Garden Biochemical High-Tech and BASF.36krAfter 10 Years of Reliance on Major Clients, Kesi Co., Ltd. Must Now Achieve Independent GrowthCosmos Co., Ltd. reported H1 2026 operating revenue of 893 million yuan, up 23.78% year-on-year, but attributable net profit fell 10.44% to 58.4807 million yuan. The sunscreen agent maker, once reliant on DSM, faces shrinking major client orders and domestic price war, with gross margin dropping to 27.89%.VenturesquareThe front seat rotates 180 degrees to become a 'lounge in the car'... DSM begins mass production of key components for the GV90.DSM announced completion of performance verification for the power swivel seat mechanism applied to the Genesis GV90 NeoLoon's electric swivel seat. The component, developed with Hyundai Transys over four years, will enter mass production in the fourth quarter of this year. DSM plans to expand its seat mechanism business for premium electric vehicles.Business RecorderIndia investigates fragrance giants over price collusion, document showsIndia's Competition Commission of India is investigating Givaudan, Firmenich, and IFF over alleged price collusion since 2024. The CCI recalled an investigation report after the companies complained that commercial secrets were not properly redacted, potentially slowing the case. The market is expected to reach $5 billion by 2033.PrtimesMedical Collagen Market to Reach US$957.4 Million by 2028, Expanding at 6.2% CAGR – PR TimesThe medical collagen market is projected to grow from US$593.7 million in 2020 to US$957.4 million by 2028, expanding at a compound annual growth rate of 6.2%. This expansion is driven by increasing demand for collagen-based products in wound care, tissue engineering, and regenerative medicine, with North America holding the largest market share in 2020. Key industry participants include Integra LifeSciences Holdings Corp., GELITA AG, and Koninklijke DSM NV, among others, who are focusing on product innovation and regulatory approvals.FinancialContent Business PageGuangdong Aodai: A Benchmark for Color-Cosmetic Manufacturing in South China, Empowering Global Beauty Brands With Full Industry-Chain CapabilitiesGuangdong Aodai Cosmetics, an affiliate of Oulilai Group, operates a smart manufacturing complex in Guangdong, China, with two R&D-production hubs capable of producing 120,000 lipsticks and 150,000 compacts daily. The company holds international certifications including ISO22716, US FDA GMP, and EU GMP, enabling it to supply global markets across Europe, America, Southeast Asia, and the Middle East. It provides one-stop OEM/ODM solutions for color cosmetics, having partnered with major raw material suppliers like BASF and DSM, and served brands such as Judydoll and Colorkey.Ticker ReportFinancial Contrast: Koninklijke DSM (OTCMKTS:RDSMY) versus Westlake Chemical Partners (NYSE:WLKP)This article provides a comparative financial analysis of Westlake Chemical Partners and Koninklijke DSM, evaluating metrics such as earnings, risk, institutional ownership, dividends, profitability, valuation, and analyst recommendations. The report concludes that Westlake Chemical Partners outperforms Koninklijke DSM across eight of the thirteen factors compared.Ticker ReportKoninklijke DSM (OTCMKTS:RDSMY) Shares Pass Below 50-Day Moving Average – Here’s WhyDuring trading on Tuesday, Koninklijke DSM's shares fell below their fifty-day moving average, trading as low as $33.11. The stock's fifty-day moving average is reported at $33.85, indicating a decline in performance as the shares last traded at this average price with a volume of 56,500. This moving average setback signals ongoing challenges for Koninklijke DSM in the market.PrtimesBiomaterials Market: Size, Growth Drivers, Emerging Trends, and Demand Outlook 2034 – PR TimesThe Insight Partners reports that the global biomaterials market was valued at US$ 248.84 Billion in 2025 and is projected to reach US$ 994.38 Billion by 2034, growing at a CAGR of 16.64%. The expansion is driven by technological advancements, the rise of smart biomaterials, and increasing demand for sustainable alternatives across medical applications such as tissue engineering and orthopedics. Key industry players including DSM, Zimmer Biomet, and Dentsply Sirona are focusing on innovation and product expansion to meet this rising global healthcare demand.TalkMarketsEnzymes Market Share by Leading CompaniesGrand View Research published a market report projecting the global enzymes market will grow from USD 14.9 billion in 2025 to USD 25.1 billion by 2033, representing a compound annual growth rate of 6.9%, with North America holding the largest revenue share at 36.3% and Asia Pacific identified as the fastest-growing regional market. The report highlights key industry trends including the shift toward sustainable biocatalysts, advances in enzyme engineering, synthetic biology, and precision fermentation technologies, while noting challenges such as raw material volatility, complex fermentation processes, and regulatory requirements around genetically modified microorganisms. Leading companies in the market include Novonesis, DSM, BASF, International Flavors & Fragrances (IFF), Associated British Foods plc, Kerry, and others, which are strengthening their positions through research and development, strategic collaborations, and manufacturing capacity expansion.